05 Aug 2021 by admin in UncategorizedComments Syros Announces Agreement with Roche to Evaluate SY-5609 as Part of a Novel Combination for Treatment of Colorectal Cancer
20 Jul 2021 by admin in UncategorizedComments Eluminex Biosciences Expands Leadership Team and Receives Award
19 Jul 2021 by admin in UncategorizedComments Eluminex Biosciences Exclusively Licenses FibroGen’s Biosynthetic Cornea Technology and Recombinant Collagen III Platform
15 Jul 2021 by admin in UncategorizedComments Adicet Bio Announces Formation of Scientific Advisory Board
09 Jul 2021 by admin in UncategorizedComments 日本中外制药(Chugai)与礼邦医药(Alebund)就 EOS789 开发用于高磷血症治疗达成期权/授权协议
06 Jul 2021 by admin in UncategorizedComments NextCure Initiates Phase 1/2 Clinical Trial of NC762 for Solid Tumors
01 Jul 2021 by admin in UncategorizedComments Tempest Announces Appointment of Christine Pellizzari to its Board of Directors
28 Jun 2021 by admin in UncategorizedComments Tempest Closes Merger with Millendo and Completes PIPE Financing
